Rapid7, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rapid7, Inc. on March 30, 2026, reporting an event that occurred on March 26, 2026. The filing details a corporate governance agreement rather than routine financial operations.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a material definitive agreement regarding board composition and does not contain financial performance data.
Material Changes
The primary material change is the entry into a Nomination and Support Agreement with JANA Partners Management, LP. Key terms include:
- Rapid7 agreed to include Kevin Galligan (the "JANA Nominee") in its slate of recommended nominees for the 2026 Annual Meeting of Stockholders.
- The Company will recommend, support, and solicit proxies for the JANA Nominee on terms no less favorable than other board nominees.
- JANA is restricted from acquiring more than 19.9% of the Company's outstanding common stock without prior Board consent.
- JANA agreed to vote its shares in favor of a specific slate of directors, including the JANA Nominee and ten other named individuals.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary on business performance. The agreement is set to terminate on the earlier of 30 days prior to the advance notice period for the 2027 annual meeting or January 8, 2027. The document notes that the summary is subject to the full text of the agreement attached as Exhibit 10.1.
Investor Verification Checklist
- Verify the full text of the Nomination and Support Agreement (Exhibit 10.1) for additional covenants or restrictions.
- Confirm the outcome of the 2026 Annual Meeting regarding the election of Kevin Galligan and the agreed-upon slate of directors.
- Monitor JANA Partners' ownership percentage to ensure it remains below the 19.9% threshold or that Board consent is obtained for any increase.
- Review the Company's proxy statement for the 2026 Annual Meeting to confirm the final slate of nominees.